Anti‐kelch‐like 12 and anti‐hexokinase 1: novel autoantibodies in primary biliary cirrhosis
暂无分享,去创建一个
G. Hirschfield | M. Gershwin | C. Bowlus | P. Milkiewicz | Z. Shums | G. Norman | D. Bloch | H. P. Ostendorff | I. Adamopoulos | P. Leung | Jinjun Wang | Chen-Yen Yang | C. Coltescu | A. Cheung | Amany S. Awad | Mark J Lim | Kenneth J. Rothschild | Harry Janssen | Amany S Awad
[1] Jiyuan Zhang,et al. CXCR5+ CD4+ T follicular helper cells participate in the pathogenesis of primary biliary cirrhosis , 2015, Hepatology.
[2] I. Mackay,et al. Ongoing activation of autoantigen‐specific B cells in primary biliary cirrhosis , 2014, Hepatology.
[3] K. Tsuneyama,et al. IL‐12/Th1 and IL‐23/Th17 biliary microenvironment in primary biliary cirrhosis: Implications for therapy , 2014, Hepatology.
[4] G. Torzilli,et al. The role of natural killer cells in autoimmune liver disease: a comprehensive review. , 2013, Journal of autoimmunity.
[5] K. Tsuneyama,et al. Clonality, activated antigen‐specific CD8+ T cells, and development of autoimmune cholangitis in dnTGFβRII mice , 2013, Hepatology.
[6] K. Lam,et al. Environment and primary biliary cirrhosis: electrophilic drugs and the induction of AMA. , 2013, Journal of autoimmunity.
[7] K. Okazaki,et al. Overexpression of microRNA-21 is associated with elevated pro-inflammatory cytokines in dominant-negative TGF-β receptor type II mouse. , 2013, Journal of autoimmunity.
[8] Yasunori Sato,et al. Increased expression of mitochondrial proteins associated with autophagy in biliary epithelial lesions in primary biliary cirrhosis , 2013, Liver international : official journal of the International Association for the Study of the Liver.
[9] G. Hirschfield,et al. The immunobiology and pathophysiology of primary biliary cirrhosis. , 2013, Annual review of pathology.
[10] K. Lam,et al. Xenobiotics and autoimmunity: does acetaminophen cause primary biliary cirrhosis? , 2012, Trends in molecular medicine.
[11] D. Bogdanos,et al. What Is New in Primary Biliary Cirrhosis? , 2012, Digestive Diseases.
[12] C. Selmi,et al. Overcoming a “Probable” Diagnosis in Antimitochondrial Antibody Negative Primary Biliary Cirrhosis: Study of 100 Sera and Review of the Literature , 2012, Clinical Reviews in Allergy & Immunology.
[13] Li Wang,et al. Identification of New Autoantigens for Primary Biliary Cirrhosis Using Human Proteome Microarrays* , 2012, Molecular & Cellular Proteomics.
[14] R. Schekman,et al. Ubiquitin-dependent regulation of COPII coat size and function , 2012, Nature.
[15] K. Lam,et al. Electrophile-modified lipoic derivatives of PDC-E2 elicits anti-mitochondrial antibody reactivity. , 2011, Journal of autoimmunity.
[16] A. Sawitzke,et al. Enzyme-linked immunosorbent assay screening then indirect immunofluorescence confirmation of antinuclear antibodies: a statistical analysis. , 2011, American journal of clinical pathology.
[17] W. Klein,et al. Amyloid-β Triggers the Release of Neuronal Hexokinase 1 from Mitochondria , 2010, PloS one.
[18] H. Nojima,et al. Nucleoredoxin Sustains Wnt/β-Catenin Signaling by Retaining a Pool of Inactive Dishevelled Protein , 2010, Current Biology.
[19] S. Pizzo,et al. Antibodies against the voltage-dependent anion channel (VDAC) and its protective ligand hexokinase-I in children with autism , 2010, Journal of Neuroimmunology.
[20] Pierre Youinou,et al. A comprehensive evaluation of serum autoantibodies in primary biliary cirrhosis. , 2010, Journal of autoimmunity.
[21] A. Granito,et al. PML Nuclear Body Component Sp140 Is a Novel Autoantigen in Primary Biliary Cirrhosis , 2010, The American Journal of Gastroenterology.
[22] P. Milkiewicz,et al. Value of autoantibody analysis in the differential diagnosis of chronic cholestatic liver disease. , 2009, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[23] D. Vergani,et al. New ELISA for detecting primary biliary cirrhosis-specific antimitochondrial antibodies. , 2009, Clinical chemistry.
[24] E. Rigopoulou,et al. Molecular diagnostics of primary biliary cirrhosis. , 2008, Expert opinion on medical diagnostics.
[25] V. Shoshan-Barmatz,et al. Hexokinase-I Protection against Apoptotic Cell Death Is Mediated via Interaction with the Voltage-dependent Anion Channel-1 , 2008, Journal of Biological Chemistry.
[26] G. Haegeman,et al. BTB Protein KLHL12 Targets the Dopamine D4 Receptor for Ubiquitination by a Cul3-based E3 Ligase* , 2008, Journal of Biological Chemistry.
[27] William M. Lee,et al. Antimitochondrial antibodies in acute liver failure: Implications for primary biliary cirrhosis , 2007, Hepatology.
[28] Gil Mor,et al. Identification of differentially expressed proteins in ovarian cancer using high-density protein microarrays , 2007, Proceedings of the National Academy of Sciences.
[29] H. Hill,et al. Comparison of Three Multiplex Immunoassays for Detection of Antibodies to Extractable Nuclear Antibodies Using Clinically Defined Sera , 2007, Annals of the New York Academy of Sciences.
[30] E. Rigopoulou,et al. Diagnostic Relevance and Clinical Significance of the New Enhanced Performance M2 (MIT3) ELISA for the Detection of IgA and IgG Antimitochondrial Antibodies in Primary Biliary Cirrhosis , 2007, Journal of Clinical Immunology.
[31] R. Cervera,et al. Circulating auto-antibodies against nuclear and non-nuclear antigens in primary Sjögren's syndrome , 2006, Clinical Rheumatology.
[32] Masahiro Ito,et al. Increased expression of nuclear envelope gp210 antigen in small bile ducts in primary biliary cirrhosis. , 2006, Journal of autoimmunity.
[33] K. Matsuo,et al. Identification of specific autoantigens in Sjögren's syndrome by SEREX , 2005, Immunology.
[34] N. Hay,et al. Mitochondrial Hexokinases: Guardians of the Mitochondria , 2005, Cell cycle.
[35] V. Shoshan-Barmatz,et al. In self-defence: hexokinase promotes voltage-dependent anion channel closure and prevents mitochondria-mediated apoptotic cell death. , 2004, The Biochemical journal.
[36] K. Lindor,et al. Combined analysis of the effect of treatment with ursodeoxycholic acid on histologic progression in primary biliary cirrhosis. , 2003, Journal of hepatology.
[37] A. Tanaka,et al. Detection of antimitochondrial autoantibodies in immunofluorescent AMA‐negative patients with primary biliary cirrhosis using recombinant autoantigens , 2001, Hepatology.
[38] M. Gerstein,et al. Global Analysis of Protein Activities Using Proteome Chips , 2001, Science.
[39] E. Heathcote. Management of primary biliary cirrhosis , 2000 .
[40] David E. J. Jones,et al. Natural history of early primary biliary cirrhosis , 1996, The Lancet.
[41] E. Dickson,et al. Use of a designer triple expression hybrid clone for three different lipoyl domain for the detection of antimitochondrial autoantibodies , 1996, Hepatology.
[42] M. Kaplan,et al. Primary biliary cirrhosis , 1998, Hepatology.
[43] F. BordaCelaya,et al. [Primary biliary cirrhosis]. , 1989, Anales de medicina interna.
[44] E. Penner,et al. Autoimmune sera recognize a 100 kD nuclear protein antigen (sp-100). , 1987, Clinical and experimental immunology.
[45] M. Kaplan,et al. Primary Biliary Cirrhosis , 1987, The New England journal of medicine.
[46] A. Floreani,et al. Nuclear membrane-staining antinuclear antibody in patients with primary biliary cirrhosis , 1985, Journal of Clinical Immunology.
[47] Mustafa Saad,et al. Implications for Therapy , 2016 .
[48] K. Tsuneyama,et al. Animal models of primary biliary cirrhosis: materials and methods. , 2012, Methods in molecular biology.
[49] I. Pandrea,et al. Implications for Therapy , 2012 .
[50] T. Skare,et al. Liver autoantibodies in patients with scleroderma , 2010, Clinical Rheumatology.
[51] E. Heathcote. Management of primary biliary cirrhosis. The American Association for the Study of Liver Diseases practice guidelines. , 2000, Hepatology.
[52] K. Lazaridis,et al. Primary biliary cirrhosis , 1998, Springer Netherlands.